Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA issues non approval letter for Helicide

Aug. 23, 2002

Thalidomide reported to be effective in the short-term treatment of symptomatic IBD

Aug. 23, 2002

Successful treatment of severe alcoholic hepatitis with urinastarine

Aug. 22, 2002

Adolor enters opioid antagonist license agreement with Lilly

Aug. 20, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

HCV NS3 protease inhibitors prepared and tested at Schering-Plough

Aug. 8, 2002

FDA advisory committee recommends approval of adefovir dipivoxil for chronic hepatitis B

Aug. 8, 2002

aaiPharma and Tanabe Seiyaku form joint venture

Aug. 2, 2002

Phase III results of CDP-571 in Crohn's disease

Aug. 2, 2002

Incara's IND for liver cell therapy approved

Aug. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...